Kotoba Okuyama

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

Kenji Nonaka, Taro Kakikawa, Asako Sato et al. · Diabetes Research and Clinical Practice · 2008 · 205 citations

Diabetes Management, Cardiovascular Disease, Diabetes +8

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

Yasuhiko Iwamoto, Tadaaki Taniguchi, Kenji Nonaka et al. · Endocrine Journal · 2010 · 97 citations · Full text

Dose-ranging Efficacy, Japanese Patients, Diabetes Management +8

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

Shinji Uchida, Tadaaki Taniguchi, Takafumi Shimizu et al. · Journal of Bone and Mineral Metabolism · 2005 · 71 citations

Bone Disease, Bone Health, Medicine +9

Disease burden and quality of life of patients with chronic cough in Japan: a population-based cross-sectional survey

Takekazu Kubo, Keisuke Tobe, Kotoba Okuyama et al. · BMJ Open Respiratory Research · 2021 · 55 citations · Full text

A randomized, placebo‐ and sitagliptin‐controlled trial of the safety and efficacy of omarigliptin, a once‐weekly dipeptidyl peptidase‐4 inhibitor, in <scp>J</scp> apanese patients with type 2 diabetes

Ira Gantz, Taro Okamoto, Yuka Ito et al. · Diabetes Obesity and Metabolism · 2017 · 32 citations · Full text